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ABSTRACT 
 
Background: Pseudomonas aeruginosa is an opportunistic pathogenic bacterium responsible for both, acute and chronic 
infection, causing serious infections in patients who are mechanically ventilated individuals, who are immunocompromised, 
and patients with malignancies or HIV infection. Objectives: The phenotypic screening of metallo beta-lactamases (MBL) in 
strains of Pseudomonas aeruginosa resistant to imipenem. Material and Methods: The study was carried out in the 
department of Microbiology, in a medical hospital, Bareilly, over a period 18 months from January 2013 to June 2014. A total 
of 103 Pseudomonas aeruginosa isolated from sputum, broncho alveolar lavage (BAL), urine, pus and blood from critically ill 
patients admitted in the intensive care unit of a tertiary care centre. Strain of P. aeruginosa resistant to imipenem, were tested 
for metallo beta-lactamase production by phenotypic methods. Result: Out of 103 Pseudomonas aeruginosa, 48 strains were 
found imipenem resistant, of which 43(89.6%) were MBL positive by imipenem -EDTA combined disc test and the rest 
35(72.9%) were by modified Hodge test. Conclusion: Imipenem – EDTA combined disc test found to be the best phenotypic 
method for detection of MBL. The appearance of the MBL and their spread among bacterial pathogens is a matter of concern 
with regard to the future of antimicrobial therapy. Both the methods are simple and one of these phenotypic methods can be 
easily incorporated in routine lab procedures to detect MBL.  
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seudomonas aeruginosa is one of the leading 
causes of nosocomial infections and due to its 
numerous intrinsic and acquired mechanisms of 
drug resistance, it is a cause of concern for treating 
clinicians. Although the antibiotic resistance in 
P.aeruginosa is caused by multiple mechanisms, one 
growing factor leading to resistance is the production of 
carbapenemases [1]. Carbapenemases are the acquired 
Metallo-β-lactamases (MBLs) which require zinc at the 
active site. They belong to Ambler's Class B and Bush-
Jacoby Mederios group 3. In India, bla Verona 
imipenemase (VIM) and NDM-1 have been reported in 
P.aeruginosa [1]. Pseudomonas aeruginosa producing 
MBLs was first reported from Japan in 1991 and since 
then these have been described from various parts of the 
world including Asia, Europe, Australia, South America 
and North America [2,3].  
 
 MBLs have the ability to hydrolyze a wide variety of 
beta lactam agents, such as penicillins, cephalosporins and 
carbapenems but not Monobactams [4]. MBLs can be 
divided into six categories according to their molecular 
structure namely- imipenem (IMP), VIM, German 
imipenemase (GIM), SIM, SPM and AIM. These enzymes 
require zinc for their catalytic activity and are inhibited by 
metal chelators, such EDTA and thiol compounds [5].   
P 
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 MBLs have recently emerged as one of the most 
problematic resistance mechanisms owing to their capacity 
to hydrolyze all beta lactams including carbapenems with 
exception of Aztreonam [6]. Acquired MBL genes are 
located on integron structures that reside on mobile genetic 
elements such as plasmids or transposons, thus enabling 
widespread dissemination [7]. Carbapenemases were 
formerly believed to be derived only from classes A, B, 
and D, but a class C carbapenemase (CMY) has been 
described. These enzymes fall into three of the Ambler 
classes of beta-lactamases A, B and D [8]. 
 MBL producing P.aeruginosa isolates have been 
report¬ed to be important causes of nosocomial infections 
across the world. These constitute 20-42 per cent of all 
noso¬comial isolates [9]. Detection of carbapenemases is 
difficult. It can be detected by phenotypic as well as 
genotypic methods [10]. Among phenotypic tests, MHT is 
a relatively easy and simple test to be performed in a 
laboratory. MHT is as the name says is the modified 
version of Hodge test which was used some years ago 
[10,11]. Even the original Hodge test was evaluated 
utilizing the PCR confirmed IMP-1 and VIM-2 MBL 
producing isolates. The original Hodge test utilized 
imipenem 10µg disc which gave fairly good results as it 
detected 67% cases of MBL producing Pseudomonas 
aeruginosa and Acinetobacter species [11]. The present 
study was undertaken to detect the prevalence of MBL in 
clinical strains of Pseudomonas aeruginosa isolated from 
ICU of  a tertiary care centre Bareilly, UP and to evaluate 
the accuracy of two phenotypic tests combined disc test & 
modified Hodge Test for the detection of MBLs in P. 
aeruginosa isolates. 
 
METHODS 
A prospective study was conducted over a period of 18 
months (January 2013 to June 2014) at the Department of 
Microbiology, in a tertiary care centre in Bareilly. This 
study was approved by the institutional ethical committee 
members and a total of 103 Pseudomonas aeruginosa were 
isolated from 243 patients. The patients and other 
concerned persons were made aware of the study and were 
signed for their consent form. The sputum, broncho 
alveolar lavage (BAL), pus, urine, blood samples from 
critically ill patients admitted in the intensive care unit of a 
tertiary care centre. 
 Specimens were inoculated on MacConkey agar, 
CLED, blood agar and blood culture bottle according to 
sample received in laboratory. The culture plates were 
aerobicaly incubated at 37°C for 18-24hrs followed by 
observation of colony characteristics, cell morphology by 
grams staining, and biochemical reaction, pseudomonas 
aeruginosa were confirmed as per standard protocol.   
 Antimicrobial sensitivity was performed on Mueller 
Hinton agar plates (Hi-Media, Mumbai) by Kirby-Bauer 
disk diffusion method according to Clinical & Laboratory 
Standards Institute (CLSI) full guidelines 2011. The 
antibiotic disks (Hi media, Mumbai, India) which were 
used are Cefepime (30µg) Ceftazidime (30 µg) 
Levofloxacin (15 µg), Amikacin (30),  Meropenem(10 
µg), Imipenem (10 µg) Cefoperazone/sulbactam (75/30µg) 
Piperacillin / Tazobactam (100/10 µg), Colistin (10 µg) 
Polymyxin(300 µg). The zone of inhibition was 
deter¬mined by measuring the disc diameter, after 
incubation of 24 hours at 37°C. P. aeruginosa ATCC 
27853 was used as control. Isolates were considered to be 
imipenem resistant when the zone around imipenem was ≤ 
13 mm, intermediate 14-15 mm and sensitive ≥16 mm. 
Among 103 P. aeruginosa isolated 48 isolates were 
imipenem resistant. All 48 Imipenem resistant 
Pseudomonas aeruginosa were screened for MBL 
production by Combined-disk method & Modified Hodge 
test. 
 In Imipenem (IMP)-EDTA combined disc test, the test 
organisms were inoculated by lawn culture technique on 
the plates of  MHA as recommended by CLSI. Imipenem 
discs of 10 μg and 750 μg Imipenem-EDTA Disk (Hi-
media SD281) were placed on the plate. The inhibition 
zones of the imipenem and imipenem-EDTA disks were 
compared after 16 to 18 hours of incubation at 37°C. In the 
combined disc test, if the increase in inhibition zone with 
the imipenem and EDTA disc was found to be ≥ 7 mm 
than the imipenem disc alone, it was considered as MBL 
positive.     
 MHT detects carbepenemase production in gram 
negative isolates. An overnight culture suspension of 
Escherichia coli ATCC 25922 adjusted to 0.5 McFarland, 
was inoculated using a sterile cotton swab on the surface 
of MHA. After drying, 10 μg imipenem discs was kept at 
the centre of the MHA plate and the test strains suspension 
was inoculated by streaking method from the edge of the 
imipenem disc to the periphery of the petri-plate in four 
different directions followed by incubating the plates at  
37°C  overnight. .  When the plates were observed, if the 
test strain that are carbenemase producing, had a presence 
of “cloverleaf shaped” zone of inhibition, then the test 
organism was considered as MBL positive. 
RESULTS 
In this prospective study where, 103 Pseudomonas 
aeruginosa stains obtained from the patients, 48 imipenem 
resistant strains of Pseudomonas aeruginosa were 
subjected to MBL detection by two phenotypic methods. 
After all the two staines were detected by two methods 
separately i.e. imipenum-EDTA combined disc test and 
MHT we found 43 (89.6%) MBL producer by Imipenem-
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EDTA combined disc test & 35 (72.9%) by MHT as 
shown in table 1. 
Table 1 - Comparison of Imipenem-EDTA Combined 
Disc Test and Modified Hodge Test 
Method  Total 
P. 
aeruginosa  
Imipenem 
Resistant 
MBL 
Positive 
% 
Imipenem-
EDTA 
Combined 
Disc Test 
103 48 43 89.6% 
Modified 
Hodge 
Test 
103 48 35 72.9% 
Inference Both are significantly correlated (p = 0.036) 
DISCUSSION 
Today, Pseudomonas aeruginosa is considered as a global 
threatening nosocomial infection and this have emerged as 
a trouble maker for the medical fraternity. Their 
remarkable growth in developing resistance to most 
antibiotic classes, including carbapenems, gives them a lot 
of importance. Hence, there is an emerging need for 
identification of the MBL and other mechanisms of drug 
resistance, else we may soon be facing end of the antibiotic 
era. These isolates also showed significant co-resistance to 
other class of antibiotics thus leaving behind only few 
therapeutic options. Therefore these β-lactamases should 
be detected routinely in clinical laboratories by using 
appropriate methods and reported to clinicians at times so 
that inappropriate use of antibiotics can be stopped on 
time. 
 Reportedly, there has been prevalence of carbapenem 
resistance mediated by obtained MBLs, particularly for 
Pseudomonas aeruginosa clinical isolates in several 
countries [12]. To prevent the necessary spread of MBL 
producing gram negative bacteria; rapid detection of MBL 
is required. One such method was performed in a study by 
Gibb et al. [12], where, using a disk with imipenem plus 
750 μg of EDTA differentiated all MBL-producing 
pseudomonads. Carbapenems have a broad spectrum of 
antibacterial activity against most aerobic and anaerobic 
Gram-positive and Gram-negative organisms.  
 Carbapenems, if not equal, are slightly more active 
than, imipenem against Gram-negative aerobic bacteria 
and slightly less active than imipenem against Gram-
positive organisms. It is stable to hydrolysis by 
dehydropeptidase. It is not hydrolyzed by most serine β-
lactamases, but like all carbapenems and penems is readily 
hydrolyzed by carbapenemases. Hence, they are often used 
as a last resort in treatment. These are resistant to 
hydrolysis by most β-lactamases including extended 
spectrum β-lactamases (ESBL) and AmpC β- lactamases.  
 There has been an increase in reports of Carbapenem 
resistance in P. aeruginosa worldwide. In India, the first 
report of MBL was published from Bangalore and they 
reported 12% of the isolates which were resistant to both 
beta lactamase inhibitors and Carbapenem and 100% of 
these isolates were found to be MBL producer [13]. 
Whereas, our study shows correlation in terms of the first 
method i.e. the Imipenem-EDTA combined disc test 
where, almost 90% of the study population was found to 
be MBL producer.  
 In India, a lot of studies have been done on MBT 
producing non fermenters and the results vary all over the 
country. It has been reported as low as 7.5% to as high as 
100% [13].  In the study done by Navaneeth BV et. al. in 
2002 found the prevalence of MBL 15/68 (22.05%) among 
carbapenem resistant isolates. These findings were not 
similar to the present study. The isolate were resistant to 
either or both Imipenem and Meropenem. The criteria for 
choosing the isolates for MBL screening are varied. Some 
studies have chosen Ceftazidime resistant strains for 
screening MBL While most of the studies have chosen 
Imipenem resistant strains for screening of MBL [14-17]. 
In our present study, 43 (89.6%) isolates of Pseudomonas 
aeruginosa were positive for Metallo β lactamases 
production by method-1 and 35 (72.9%) were positive by 
method-2.  
 This study results demonstrate the serious therapeutic 
and epidemiological threat of the spread of MBL 
producing Pseudomonas aeruginosa. In this study, 
Imipenem-EDTA combined disc test was found to be best 
screening tests followed by MHT. This study has a 
limitation of sampling, since all the samples were taken 
from a single hospital and a study with patients varying in 
locations, is suggested to get more précised and accurate 
results.  
 
CONCLUSION 
The β-lactamases should be detected routinely in clinical 
laboratories by using appropriate methods and reported to 
clinicians at times so that inappropriate use of antibiotics 
can be stopped on time. Excellent antimicrobial policies 
and infection control implementation are important 
priorities for the critical patient areas. 
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